Diagnostics
R-Biopharm Australia’s diagnostic technology portfolio combines advanced automation, intelligent workflow design and innovative molecular diagnostics to support laboratories of every size. From semi-automated nucleic acid extraction to high-performance Multiplex Tandem PCR (MT-PCR) platforms, our technologies streamline sample processing, improve laboratory efficiency and deliver reliable, reproducible results. Whether supporting routine clinical testing or high-throughput molecular diagnostics, our integrated solutions help laboratories work with greater confidence and consistency.
Integrated Diagnostic Workflows
Modern molecular laboratories require more than standalone instruments, they need technologies that work seamlessly together to deliver efficient, reliable diagnostic results. R-Biopharm Australia’s diagnostic workflow solutions integrate semi-automated nucleic acid extraction with advanced MT-PCR processing, creating end-to-end workflows that reduce manual handling, minimise opportunities for error and improve overall laboratory productivity. With solutions designed for both medium- and high-throughput environments, laboratories can implement workflows that align with their operational requirements while maintaining consistent, high-quality performance.
Discover How Our Diagnostic Technology Works
Diagnostic Technology Workflows
Reliable products and high quality are standard in clinical laboratories. Moreover, time and costs play an increasingly important role, which can optimally be addressed with suitable automation solutions. In cooperation with renowned partners, R-Biopharm offers equipment and software solutions from small to high sample throughput for your specific laboratory requirements.
How It Works
Explore the inner workings of R-Biopharm Australia’s patented Multiplex Tandem PCR (MT-PCR) process.
Extraction Solutions
Reliable nucleic acid extraction forms the foundation of every successful molecular diagnostic workflow. R-Biopharm Australia’s extraction technologies combine proven magnetic bead purification with intelligent automation to deliver high-quality DNA and RNA suitable for downstream molecular analysis. Whether laboratories require flexible processing for smaller sample volumes or scalable automation for high-throughput testing, our extraction platforms provide dependable performance, reproducible results and seamless integration with downstream PCR technologies.
Advanced Syndromic Testing
R-Biopharm Australia’s syndromic testing platforms utilise patented Multiplex Tandem PCR (MT-PCR) technology to detect multiple clinically relevant pathogens and genetic markers from a single sample. By combining sensitive molecular detection with automated workflow management, these platforms simplify complex diagnostic testing while reducing turnaround times and improving laboratory efficiency. Designed for both medium- and high-throughput laboratories, our solutions provide the flexibility and scalability needed to support modern molecular diagnostics.
Precision PCR Technologies
Our PCR technology portfolio delivers the accuracy, sensitivity and reliability required for today’s molecular diagnostic laboratories. Designed to integrate seamlessly into automated workflows, these platforms support rapid amplification and precise detection across a wide range of clinical applications. With intuitive operation, dependable performance and compatibility with R-Biopharm’s broader diagnostic ecosystem, our PCR solutions help laboratories optimise efficiency while maintaining confidence in every result.
RIDA®Cycler 384
1 – 48 samples per run
Rapid and compact qPCR processing with
automated centrifugation
Complete Diagnostic Technology Solutions
R-Biopharm Australia’s diagnostic technology portfolio brings together semi-automated extraction systems, advanced MT-PCR platforms and precision PCR instruments to create complete molecular diagnostic workflows. Supported by local technical expertise, our technologies help laboratories increase efficiency, improve consistency and deliver fast, accurate results across a broad range of clinical applications. Whether expanding testing capacity or implementing a new molecular workflow,
R-Biopharm provides the technology to support every stage of the diagnostic process.
